Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Krimsky

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
JAMA|October 27, 1999
Conflict of interest and cost-effectiveness analysisS Krimsky
Recombinant DNA Technical Bulletin|June 1, 1982
Local monitoring of biotechnology: the second wave of recombinant DNA lawsS Krimsky
Human Gene Therapy|January 1, 1990
Human gene therapy: must we know where to stop before we start?S Krimsky
Recombinant DNA Technical Bulletin|April 1, 1981
Patients for life forms sui generis: some new questions for science, law and societyS Krimsky
Annals of the New York Academy of Sciences|January 25, 2002
An epistemological inquiry into the endocrine disruptor thesisS Krimsky
Science (New York, N.Y.)|February 17, 1995
Biotechnology regulationS Krimsky
Psychotherapy and Psychosomatics|May 8, 2001
Journal policies on conflict of interest: if this is the therapy, what's the disease?S Krimsky
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|February 1, 1989
Science, biopolitics and risk: margins of uncertaintyS Krimsky
Nature|January 10, 1980
The ties that bind or benefitS Krimsky, D Baltimore
American Journal of Public Health|December 1, 1979
Recombinant DNA research: the scope and limits of regulationS Krimsky, D Ozonoff
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
JAMA|October 27, 1999
Conflict of interest and cost-effectiveness analysisS Krimsky
Recombinant DNA Technical Bulletin|June 1, 1982
Local monitoring of biotechnology: the second wave of recombinant DNA lawsS Krimsky
Human Gene Therapy|January 1, 1990
Human gene therapy: must we know where to stop before we start?S Krimsky
Recombinant DNA Technical Bulletin|April 1, 1981
Patients for life forms sui generis: some new questions for science, law and societyS Krimsky
Annals of the New York Academy of Sciences|January 25, 2002
An epistemological inquiry into the endocrine disruptor thesisS Krimsky
Science (New York, N.Y.)|February 17, 1995
Biotechnology regulationS Krimsky
Psychotherapy and Psychosomatics|May 8, 2001
Journal policies on conflict of interest: if this is the therapy, what's the disease?S Krimsky
Politics and the Life Sciences : the Journal of the Association for Politics and the Life Sciences|February 1, 1989
Science, biopolitics and risk: margins of uncertaintyS Krimsky
Nature|January 10, 1980
The ties that bind or benefitS Krimsky, D Baltimore
American Journal of Public Health|December 1, 1979
Recombinant DNA research: the scope and limits of regulationS Krimsky, D Ozonoff
Pageof 6